Benidipine protects kidney through inhibiting ROCK1 activity and reducing the epithelium-mesenchymal transdifferentiation in type 1 diabetic rats

Journal of Diabetes Research

Volumn 2013, Issue , 2013, Pages

  Wu, Ganlin ^a   Xu, Meirong ^a   Xu, Kui ^a   Hu, Yilan ^b  

^a HUBEI UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b WUHAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BENIDIPINE; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; RHO KINASE; ROCK1 PROTEIN, RAT;

ANIMAL; ARTICLE; CELL PROTECTION; CELL TRANSDIFFERENTIATION; DIABETIC NEPHROPATHY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; EPITHELIAL MESENCHYMAL TRANSITION; EXPERIMENTAL DIABETES MELLITUS; FIBROSIS; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY; MALE; PATHOLOGY; RAT; WISTAR RAT;

ANIMALS; CALCIUM CHANNEL BLOCKERS; CELL TRANSDIFFERENTIATION; CYTOPROTECTION; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; DIHYDROPYRIDINES; EPITHELIAL-MESENCHYMAL TRANSITION; FIBROSIS; KIDNEY; MALE; RATS; RATS, WISTAR; RHO-ASSOCIATED KINASES;

EID: 84893749273     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2013/174526     Document Type: Article

References (23)

1. 2+ channel (α 1G) expressed in Xenopus oocytes. Journal of Cardiovascular Pharmacology 2005 45 3 241 246 2-s2.0-14744275684 10.1097/01.fjc.0000154374.88283.15 (Pubitemid 40328146)
2. Prakash J., De Borst M. H., Lacombe M., Opdam F., Klok P. A., Van Goor H., Meijer D. K. F., Moolenaar F., Poelstra K., Kok R. J., Inhibition of renal Rho kinase attenuates ischemia/reperfusion-induced injury. Journal of the American Society of Nephrology 2008 19 11 2086 2097 2-s2.0-55749097408 10.1681/ASN.2007070794
3. Masszi A., Di Ciano C., Sirokmány G., Arthur W. T., Rotstein O. D., Wang J., McCulloch C. A. G., Rosivall L., Mucsi I., Kapus A., Central role for Rho in TGF- β 1-induced α -smooth muscle actin expression during epithelial-mesenchymal transition. American Journal of Physiology: Renal Physiology 2003 284 5 F911 F924 2-s2.0-0037405501 (Pubitemid 36443575)
4. Nagatoya K., Moriyama T., Kawada N., Takeji M., Oseto S., Murozono T., Ando A., Imai E., Hori M., γ -27632 prevents tubulointerstitial fibrosis in mouse kidneys with unilateral ureteral obstruction. Kidney International 2002 61 5 1684 1695 2-s2.0-0036236193 10.1046/j.1523-1755.2002.00328.x (Pubitemid 34437922)
5. Sugano N., Wakino S., Kanda T., Tatematsu S., Homma K., Yoshioka K., Hasegawa K., Hara Y., Suetsugu Y., Yoshizawa T., Hara Y., Utsunomiya Y., Tokudome G., Hosoya T., Saruta T., Hayashi K., T-type calcium channel blockade as a therapeutic strategy against renal injury in rats with subtotal nephrectomy. Kidney International 2008 73 7 826 834 2-s2.0-40849085208 10.1038/sj.ki.5002793 (Pubitemid 351398286)
6. Meyer-Schwesinger C., Dehde S., Sachs M., Rho-kinase inhibition prevents proteinuria in immune-complex-mediated antipodocyte nephritis. American Journal of Physiology: Renal Physiology 2012 303 7 F1015 F1025
7. Hahmann C., Schroeter T., Rho-kinase inhibitors as therapeutics: from pan inhibition to isoform selectivity. Cellular and Molecular Life Sciences 2010 67 2 171 177 2-s2.0-73849126315 10.1007/s00018-009-0189-x
8. Gao S.-Y., Li C.-Y., Chen J., Pan L., Saito S., Terashita T., Saito K., Miyawaki K., Shigemoto K., Mominoki K., Matsuda S., Kobayashi N., Rho-ROCK signal pathway regulates microtubule-based process formation of cultured podocytes-inhibition of ROCK promoted process elongation. Nephron 2004 97 2 e49 e61 2-s2.0-1842661441 10.1159/000078406
9. Gu L., Gao Q., Ni L., Wang M., Fasudil S. F., Inhibits epithelial-myofibroblast transdifferentiation of human renal tubular epithelial HK-2 cells induced by high glucose. Chemical and Pharmaceutical Bulletin 2013 61 7 688 694
10. Mauri V., Lotfi P., Segatori L., Sardiello M., A rapid and sensitive method for measuring N-acetylglucosaminidase activity in cultured cells. PLoS ONE 2013 8 6 e68060
11. Jeruschke S., Büscher A. K., Oh J., Protective effects of the mTOR inhibitor everolimus on cytoskeletal injury in human podocytes are mediated by RhoA signaling. PLoS ONE 2013 8 2 e55980
12. Wettschureck N., Offermanns S., Rho/Rho-kinase mediated signaling in physiology and pathophysiology. Journal of Molecular Medicine 2002 80 629 638 10.1007/s00109-002-0370-2 (Pubitemid 35471727)
13. Bach L. A., Rho kinase inhibition: a new approach for treating diabetic nephropathy? Diabetes 2008 57 3 532 533 2-s2.0-40949113247 10.2337/db07-1768
14. Kolavennu V., Zeng L., Peng H., Wang Y., Danesh F. R., Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control. Diabetes 2008 57 3 714 723 2-s2.0-40949137434 10.2337/db07-1241
15. Yao K., Nagashima K., Miki H., Pharmacological, pharmacokinetic, and clinical properties of benidipine hydrochloride, a novel, long-acting calcium channel blocker. Journal of Pharmacological Sciences 2006 100 4 243 261 2-s2.0-33645846938 10.1254/jphs.DTJ05001X
16. 2+ channel blocker, on expression of cytokine-induced adhesion molecules and chemoattractants in human aortic endothelial cells. European Journal of Pharmacology 2004 498 1-3 303 314 2-s2.0-4444289984 10.1016/j.ejphar.2004.07.086 (Pubitemid 39208093)
17. 2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R. European Journal of Pharmacology 2008 584 2-3 424 434 2-s2.0-41149181485 10.1016/j.ejphar.2008.02.001
18. Jesmin S., Hattori Y., Maeda S., Zaedi S., Sakuma I., Miyauchi T., Subdepressor dose of benidipine ameliorates diabetic cardiac remodeling accompanied by normalization of upregulated endothelin system in rats. American Journal of Physiology: Heart and Circulatory Physiology 2006 290 5 H2146 H2154 2-s2.0-33646402895 10.1152/ajpheart.01142.2005
19. Ono T., Liu N., Kusano H., Nogaki F., Makino T., Muso E., Sasayama S., Broad antiproliferative effects of benidipine on cultured human mesangial cells in cell cycle phases. American Journal of Nephrology 2002 22 5-6 581 586 2-s2.0-0036977155 10.1159/000065266 (Pubitemid 36158524)
20. + channels TRAM-34 blocks growth of hepatocellular carcinoma cells via downregulation of estrogen receptor alpha mRNA and nuclear factor-kappaB. Investigational New Drugs 2012
21. Pluteanu F., Cribbs L. L., Regulation and function of Cav3.1 T-type calcium channels in IGF-I-stimulated pulmonary artery smooth muscle cells. American Journal of Physiology: Cell Physiology 2011 300 3 C517 C525 2-s2.0-79952129860 10.1152/ajpcell.00107.2010
22. Yamamoto Y., Shioda N., Han F., Moriguchi S., Fukunaga K., The novel cognitive enhancer ST101 enhances acetylcholine release in mouse sorsal hippocampus through T-type voltage-gated calcium channel stimulation. Journal of Pharmacological Sciences 2013
23. Howitt L., Kuo I. Y., Ellis A., Chronic deficit in nitric oxide elicits oxidative stress and augments T-type calcium channel contribution to vascular tone of rodent arteries and arterioles. Cardiovascular Research 2013